Determining Metabolic Effects of Valproate and Antipsychotic Therapy

Completed · Not applicable · Has a placebo group

Conditions studied: Schizophrenia

In brief

This study will determine the metabolic processes responsible for high levels of blood glucose, metabolism disorders, and weight gain in people with schizophrenia who have been treated with antipsychotic medications in combination with valproate.

Key facts

Study ID
NCT00167934
Run by
Washington University School of Medicine
People needed
164
Starts
2004-12-01
Expected to finish
2008-12-01
Last updated by the study team
2020-02-10

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.